Abbott Laboratories (ABT) Operating Leases (2019 - 2021)

Abbott Laboratories (ABT) has 3 years of Operating Leases data on file, last reported at $956.0 million in Q4 2021.

• For the quarter ending Q4 2021, Operating Leases rose 5.99% year-over-year to $956.0 million; the trailing twelve-month figure through Dec 2021 stood at $956.0 million (up 5.99% YoY), and the FY2021 full-year result was $956.0 million, up 5.99% from the prior year.
• Operating Leases advanced to $956.0 million in Q4 2021, from $902.0 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $956.0 million in Q4 2021 to a low of $755.0 million in Q4 2019.
• A 3-year average of $871.0 million and a median of $902.0 million in 2020 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases gained 19.47% in 2020 and climbed 5.99% in 2021, its largest moves.
• Tracing ABT's Operating Leases over 3 years: stood at $755.0 million in 2019, then advanced by 19.47% to $902.0 million in 2020, then rose by 5.99% to $956.0 million in 2021.
• Business Quant data shows ABT's Operating Leases at $956.0 million in Q4 2021, $902.0 million in Q4 2020, and $755.0 million in Q4 2019.